Delisting risk
CRIS · NASDAQ · Biotechnology

Curis (CRIS)

Develops emavusertib combinations for primary central nervous system lymphoma and chronic lymphocytic leukemia.

$1.40
Pre-market+0.01 (+0.43%)
At close$1.39(−2.11%)

Breakdown13F · 13D/G · Form 4

Institutions42 holders · as of Mar 31, 202640.45%788.3K shares
Insiders6 holders · as of Apr 1, 20261.02%20.0K shares
Otherremainder58.53%1.14M shares

1.95M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Bleichroeder LPInstitution
9.75%3.80M13Fas of Mar 31, 2026
Stonepine Capital Management, LLCInstitution
9.56%3.73M13Fas of Mar 31, 2026
Nantahala Capital Management, LLCInstitution
5.13%2.00M13Fas of Mar 31, 2026
Sphera Funds Management Ltd.Institution
5.12%1.99M13Fas of Mar 31, 2026
Cable Car Capital LLCInstitution
3.42%1.33M13Fas of Mar 31, 2026
Dauntless Investment Group, LLCInstitution
1.69%658,72513Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution
0.96%374,32613Fas of Mar 31, 2026
Renaissance Technologies LLCInstitution
0.94%366,74013Fas of Mar 31, 2026
M28 Capital Management LPInstitution
0.73%284,88913Fas of Mar 31, 2026
Morgan StanleyInstitution
0.65%254,24513Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution
0.43%168,32713Fas of Mar 31, 2026
CM Management, LLCInstitution
0.38%150,00013Fas of Mar 31, 2026
James E. DentzerInsiderdirector, officer: President & CEO
0.38%7,437Form 4filed Mar 23, 2026
Focused Wealth Management, IncInstitution
0.28%109,74613Fas of Mar 31, 2026
Diantha DuvallInsiderofficer: CFO
0.20%3,885Form 4filed Mar 23, 2026
Citadel Advisors LLCInstitution
0.17%67,01813Fas of Mar 31, 2026
Ahmed MD HamdyInsiderofficer: CMO
0.17%3,333Form 4filed Mar 23, 2026
Jonathan B. ZungInsiderofficer: CDO
0.17%3,333Form 4filed Mar 23, 2026
Boothbay Fund Management, LLCInstitution
0.16%62,16813Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution
0.16%61,66413Fas of Mar 31, 2026
Squarepoint Ops LLCInstitution
0.15%58,03513Fas of Mar 31, 2026
BlackRock, Inc.Institution
0.14%53,48413Fas of Mar 31, 2026
Maverick Capital LtdInstitution
0.13%49,55413Fas of Mar 31, 2026
Prudential Financial IncInstitution
0.09%35,40013Fas of Mar 31, 2026
HRT Financial LPInstitution
0.07%28,32913Fas of Mar 31, 2026

13F — a manager's quarterly holdings · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

42 holders · 15.77M shares · 12 new positions · 26 increased · 6 reduced · 10 closed

HolderShares% outstandingChg q/qFiled
Bleichroeder LP3.80M195.10%+2.67MMay 14, 2026
Stonepine Capital Management, LLC3.73M191.20%+3.67MMay 14, 2026
Nantahala Capital Management, LLC2.00M102.62%+2.00MnewMay 15, 2026
Sphera Funds Management Ltd.1.99M102.36%+1.99MnewMay 15, 2026
Cable Car Capital LLC1.33M68.41%+1.33MnewMay 15, 2026
Dauntless Investment Group, LLC658.7K33.80%+658.7KnewMay 14, 2026
Vanguard Capital Management LLC374.3K19.21%+374.3KnewMay 15, 2026
Renaissance Technologies LLC366.7K18.82%+125.8KMay 14, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Nantahala Capital Management, LLC9.99%13GApr 24, 2026
Armistice Capital, LLC9.99%13GAug 14, 2025
Thomas A. Satterfield, Jr.9.90%13GMay 14, 2026
Stonepine Capital Management, LLC9.90%13GMar 27, 2026
Bleichroeder LP9.90%13GMar 31, 2025
Nantahala Capital Partners Limited Partnership6.98%13GApr 7, 2026

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Mar 31, 2026
Kenneth I. Kaitindirector
Purchase10,000$0.548711,407

CongressHouse and Senate disclosures

Not reported.